This announcement is a separate document:
京新药业：董事会审计委员会议事规则（2024年3月修订）
Jingxin Pharmaceutical: Rules of Procedure for Audit Committee of the Board of Directors (revised in March 2024)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.